Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
University Hospital, Strasbourg, France
City of Hope Medical Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Institut Bergonié
M.D. Anderson Cancer Center
City of Hope Medical Center
Emory University
OHSU Knight Cancer Institute
University of Kansas Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Emory University
Mayo Clinic
Roswell Park Cancer Institute
The Hospital for Sick Children
Abramson Cancer Center at Penn Medicine
University of Chicago
University of Chicago
Mayo Clinic
City of Hope Medical Center
Brigham and Women's Hospital
Stanford University
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
University of California, San Francisco
Massachusetts General Hospital
Dana-Farber Cancer Institute
Yale University
Mayo Clinic
Le Bonheur Children's Hospital
University of Southern California
Washington University School of Medicine
Eastern Hepatobiliary Surgery Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Children's Hospital of Philadelphia
University of Chicago
University of Chicago
University of Chicago